Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02271
Species: Homo sapiens
Position : chr1:214150511-214151337
Year: 2015
Title: GATA2 is required for lymphatic vessel valve development and maintenance.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lymphedema
PMID:  26214525
MONDO: MONDO:0019297
Tissue: dermis
Tissue Ontology ID: UBERON:0002067
Cell Source: Primary adult human dermal lymphatic endothelial cells (hLECs)
Cell Type: endothelial cell
Cell Ontology ID: CL:0000115
Experiment Type: TF binding assay; Enhancer activity assay
High Throughput Method: GATA2 ChIP-seq; ENCODE regulatory annotation integration
Low Throughput Method: ChIP-qPCR; Luciferase Reporter Assay
About Target Gene
Target gene : PROX1
About TF
TF name : FOXC2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 11 found
Enhancer ID Position Tissue Cell Disease
E_02200 chr1:214150511-214151337 dermis endothelial cell lymphedema
E_02272 chr1:214150511-214151337 dermis endothelial cell lymphedema
E_02284 chr1:214150511-214151337 lymphatic vessel NA Lymphedema
E_02285 chr1:214150511-214151337 lymphatic vessel NA Lymphedema
E_02286 chr1:214150511-214151337 lymphatic vessel NA Lymphedema
E_02266 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02273 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02274 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02275 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02276 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
E_02277 chr1:214150857-214151185 lymphatic vessel endothelial cell acute myeloid leukemia
Expression of Target Genes for the Enhancer